Skip to main content
See every side of every news story
Published loading...Updated

‘Not cosmetic’: NH lawmaker wants state to cover GLP-1 drugs for weight loss

Summary by Nhpr
As of January, New Hampshire’s Medicaid program has ended coverage for GLP-1 drugs like Saxenda, Wegovy and Zepbound for weight loss. The state still covers the medications when they’re part of a treatment plan for other chronic conditions. A bill under consideration at the State House would require the state to provide GLP-1 medications under the state Medicaid plan as a treatment for people with obesity.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

nhpr broke the news in New Hampshire, United States on Monday, April 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal